Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia

International Journal of Antimicrobial Agents

Volumn 37, Issue 3, 2011, Pages 240-243

  Hassing, Robert Jan ^a,b   Menezes, Godfred A ^c   Van Pelt, Wilfred ^d   Petit, Pieter L ^e   Van Genderen, Perry J ^b   Goessens, Wil H F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Harbour Hospital   (Netherlands)

^c JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e Vlietland Hospital   (Netherlands)

Author keywords

Ciprofloxacin; DNA gyrase; Drug resistance; Efflux pump; Plasmids; Typhoid fever

Indexed keywords

BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; EFFLUX PUMP; NALIDIXIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENOTYPE; GYRA GENE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEROTYPE; SOUTHEAST ASIA; TRAVEL;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; BLOOD; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; PARATYPHOID FEVER; PLASMIDS; POLYMERASE CHAIN REACTION; QUINOLONES; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; TRAVEL; TYPHOID FEVER;

EID: 79951941829     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.10.026     Document Type: Article

References (17)

1. M.K. Bhan, R. Bhal, and S. Bhatnagar Typhoid and paratyphoid fever Lancet 366 2005 749 762 (Pubitemid 41207239)
2. J. Wain, N.T.T. Hoa, N.T. Chinh, H. Vinh, M.J. Everett, and T.S. Diep Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment Clin Infect Dis 25 1997 1404 1410 (Pubitemid 28022680)
3. E.J. Threlfall, and L.R. Ward Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom Emerg Infect Dis 7 2001 448 450
4. L.J.V. Piddock Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994 Drugs 49 Suppl. 2 1995 29 35
5. L. Cebrián, J.C. Rodríques, I. Escribano, and G. Royo Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms Chemotherapy 51 2005 40 43 (Pubitemid 41201972)
6. C.S. Toro, S.R. Lobos, I. Calderón, M. Rodríguez, and G.C. Mora Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol Antimicrob Agents Chemother 34 1990 1715 1719 (Pubitemid 20259499)
7. U.O. Hasdemir, J. Chevalier, P. Nordmann, and J.M. Pagés Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey J Clin Microbiol 42 2004 2701 2706 (Pubitemid 38747524)
8. S. Kariuki, G. Revathi, J. Muyodi, J. Mwituria, A. Munyalo, and S. Mirza Characterization of multidrug-resistant typhoid outbreaks in Kenya J Clin Microbiol 42 2004 1477 1482 (Pubitemid 38500784)
9. J.J. Wu, W.C. Ko, S.H. Tsai, and J.J. Yan Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital Antimicrob Agents Chemother 51 2007 1223 1227
10. A. Robicsek, J. Strahilevitz, G.A. Jacoby, M. Macielag, D. Abbanat, and C.H. Park Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Nat Med 12 2006 83 88 (Pubitemid 43050081)
11. C. Lévesque, L. Piché, C. Larose, and P.H. Roy PCR mapping of integrons reveals several novel combinations of resistance genes Antimicrob Agents Chemother 39 1995 185 191
12. R. Slinger, M. Desjardins, A.E. McCarthy, K. Ramotar, P. Jessamine, and C. Guibord Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series BMC Infect Dis 4 2004 36
13. R. Gaind, B. Paglietti, M. Murgia, R. Dawar, S. Uzzau, and P. Cappuccinelli Molecular characterization of ciprofloxacin-resistant Salmonella enteric serovar Typhi and Paratyphi A causing enteric fever in India J Antimicrob Chemother 58 2006 1139 1144 (Pubitemid 44884131)
14. S. Nair, M. Unnikrishnan, K. Turner, S.C. Parija, C. Churcher, and J. Wain Molecular analysis of fluoroquinolone-resistant Salmonella Paratyphi A isolate, India Emerg Infect Dis 12 2006 489 491
15. K. Gay, A. Robicsek, J. Strahilevitz, C.H. Park, G. Jacoby, and T.J. Barrett Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica Clin Infect Dis 43 2006 297 304 (Pubitemid 44078900)
16. P.M.A. Shanahan, M.V. Jesudason, C.J. Thomson, and S.G.B. Amyes Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India J Clin Microbiol 36 1998 1595 1600 (Pubitemid 28226036)
17. M.D. Tamang, J.Y. Oh, S.Y. Seol, H.Y. Kang, J.C. Lee, and Y.C. Lee Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal Int J Antimicrob Agents 30 2007 330 335 (Pubitemid 47361708)